Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President-Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Marc Frahm | Cowen |
Salveen Richter | Goldman Sachs |
Brian Ayman | Jefferies |
Tyler Van Buren | Piper Sandler |
John Newman | Canaccord |
Cory Kasimov | JPMorgan |
Michael Schmidt | Guggenheim |
Mark Breidenbach | Oppenheimer |
Dane Leone | Raymond James |
Reni Benjamin | JMP Securities |
Raju Prasad | William Blair |
Asthika Goonewardene | Truist Securities |
Luca Issi | RBC Capital |
Ben Burnett | Stifel |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be aware that today's conference call is being recorded.